USA-based Agios Pharmaceuticals has announced that the ACTIVATE-Kids Phase III study of mitapivat in children aged 1 to <18 ...

ACTIVATE-Kids is the First Study to Demonstrate Efficacy of an Oral Therapy for Children with PK Deficiency Who Are Not Regularly Transfused –– ...

SL1009 is expected to increase energy production by inhibiting pyruvate dehydrogenase kinase and stimulating residual pyruvate dehydrogenase complex activity. The NDA is supported by data from a ...

The draft regulation by the University Grants Commission (UGC) on the selection and appointment of vice chancellors of universities has evoked protests by non-Bharatiya Janata Party-headed State ...

The purpose of this study was to investigate whether circulating pyruvate kinase M2 (PK‐M2) levels are elevated in the peripheral blood and to assess their association with diagnosis and prognosis in ...

His experience and the takeaway from the conversation with Gartner clients is that the EU AI Act builds on the General Data Protection Regulation (GDPR). Under the GDPR, data must be collected for ...